Peer-reviewed veterinary case report
Blood test ratios linked to survival in dogs with parvovirus
By González-Domínguez, Andrea et al.·Published in Journal of veterinary internal medicine·2024·Veterinary Teaching Hospital of the Catholic University of Valencia-Emergency and critical care, Spain·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Retrospective evaluation of hematological ratios in canine parvovirosis: 401 cases.
- Species:
- dog
Plain-English summary
A group of 401 dogs diagnosed with parvovirus (CPV) were evaluated to see if certain blood ratios could help predict their chances of survival. Most of the dogs, about 84%, survived after treatment, but those that didn't had higher platelet-to-lymphocyte ratios (PLR) and lower lymphocyte counts when they were admitted to the hospital. The study found that a PLR above 700 could indicate a higher risk of not surviving. This suggests that measuring these blood ratios at the time of admission could help vets assess how severe the disease is and guide treatment decisions.
People also search for: dog parvovirus survival rate · dog blood test results explained · parvovirus treatment for dogs
Abstract
BACKGROUND: The utility of neutrophil-to-lymphocyte ratio (NLR), platelet to-lymphocyte ratio (PLR) and monocyte-to-lymphocyte ratio (MLR) as prognostic indicators has not been investigated in canine parvovirosis (CPV). HYPOTHESIS: To evaluate whether these hematological ratios obtained at hospital admission in CPV are associated with outcome or duration of hospitalization. ANIMALS: Four hundred one client-owned dogs presented with CPV. Methods-Retrospective multicenter cohort study. Medical records were reviewed to identify dogs with CPV. Data regarding signalment, complete blood count at admission, duration of hospitalization and outcome were collected. RESULTS: Of the 401 dogs included in the study, 336 (83.8%) survived to discharge. The median (25th and 75th percentiles) PLR in nonsurvivors (336.56 [159.84-635.77]) was significantly higher than in survivors (217.65 [117.67-389.65]) (P = .003). The area under the receiver-operating characteristic curve for nonsurvival was 0.615 (95% CI [0.593-0.691], P = .003). A cut off of 700 showed a 21.5% sensitivity and 90% specificity for nonsurvival. No association was observed between hospitalization duration and either hematological ratios or total WBC counts. The median (25th and 75th percentiles) lymphocyte count was below reference interval in all dogs and was significantly lower in the dogs which died (0.82 × 10/L [0.5-1.87]) than in survivors (1.27 × 10/L [0.73-2.22]) (P = .005). The median (25th and 75th percentiles) monocyte count however was lower in survivors (0.38 × 10/L [0.29-1.59]), than in nonsurvivors (0.73 × 10/L [0.1-2]) (P = .002). CONCLUSIONS: Evaluation of PLR at hospital admission might be a useful marker of disease severity and could have prognostic value in dogs with CPV.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/38100467/